摘要
目的观察左卡尼汀联合卡托普利治疗急性病毒性心肌炎的临床疗效。方法将82例急性病毒性心肌炎患者随机分为治疗组和对照组,对照组给予常规治疗,治疗组在常规治疗基础上给予左卡尼汀与卡托普利联合治疗。结果治疗组治愈率为75.6%,高于对照组的43.9%(P<0.05);治疗组总有效率为95.1%,高于对照组的82.5%(P<0.05);治疗组治疗效果优于对照组,且治疗组血清心肌酶及心电图的改善情况也均明显优于对照组(P<0.05)。结论在常规治疗基础上加左卡尼汀联合卡托普利对急性病毒性心肌炎有较好疗效。
Objective To observe the therapeutic effect of Levocaruitine and Captopril on acute viral myocarditis. Methods 82 patients with viral myocarditis were randomly divided into treatment group and the control group. The control group received routine treatment,and treatment group received Levocarnitine （2.0 g/d,iv x 14 d） and Captopril （12.5 mg/d, pox 15 d, bid）in addition to the routine treatment. Results After the treatment,75.6% recovered in treatment group compared with 43.9% in the control group （P 〈 0.05 ）, and 95. 1% total effective rate in treatment group compared with 82.5 % in the control group（ P 〈 0.05 ）. Besides the improvements of serum myocardium - enzyme and electrecardiogram in the treatment group were distinctly better than that of the control group. Conclusion Levocaruitine combined with Captopril in addition to the routine therapy on acute viral myocarditis has a good effect.
出处
《中国医学创新》
CAS
2010年第23期10-12,共3页
Medical Innovation of China
